Guinea

Guinea

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
11.74 (9.47 - 13.58) 2019 Modelled IHME
12.13 (9.77 - 13.96) 2018 Modelled IHME
12.52 (9.95 - 14.56) 2017 Modelled IHME
12.9 (10.27 - 14.90) 2016 Modelled IHME
13.26 (10.50 - 15.49) 2015 Modelled IHME
13.55 (10.80 - 15.69) 2014 Modelled IHME
13.81 (11.13 - 15.89) 2013 Modelled IHME
14.06 (11.50 - 16.16) 2012 Modelled IHME
14.29 (11.73 - 16.51) 2011 Modelled IHME
14.53 (11.86 - 16.98) 2010 Modelled IHME
14.79 (11.96 - 17.23) 2009 Modelled IHME
15.09 (11.98 - 17.64) 2008 Modelled IHME
15.38 (12.05 - 18.08) 2007 Modelled IHME
15.6 (12.03 - 18.50) 2006 Modelled IHME
15.71 (12.04 - 18.70) 2005 Modelled IHME
15.74 (12.18 - 18.60) 2004 Modelled IHME
15.77 (12.29 - 18.41) 2003 Modelled IHME
15.79 (12.38 - 18.34) 2002 Modelled IHME
15.82 (12.52 - 18.40) 2001 Modelled IHME
15.86 (12.55 - 18.52) 2000 Modelled IHME
16.02 (12.69 - 18.57) 1999 Modelled IHME
16.36 (12.84 - 19.09) 1998 Modelled IHME
16.75 (12.96 - 19.75) 1997 Modelled IHME
17.07 (13.03 - 20.30) 1996 Modelled IHME
17.22 (13.07 - 20.54) 1995 Modelled IHME
17.23 (13.20 - 20.37) 1994 Modelled IHME
17.23 (13.26 - 20.28) 1993 Modelled IHME
17.2 (13.37 - 20.14) 1992 Modelled IHME
17.15 (13.39 - 20.01) 1991 Modelled IHME
17.04 (13.35 - 19.77) 1990 Modelled IHME
13 (6.61 - 21.79) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
6.36 (4.26 - 8.06) 2019 Modelled IHME
7.11 (4.61 - 8.82) 2018 Modelled IHME
7.42 (4.75 - 9.38) 2017 Modelled IHME
7.3 (4.65 - 9.23) 2016 Modelled IHME
7.08 (4.50 - 9.15) 2015 Modelled IHME
6.83 (4.34 - 8.85) 2014 Modelled IHME
6.51 (4.15 - 8.41) 2013 Modelled IHME
6.19 (3.99 - 8.03) 2012 Modelled IHME
5.95 (3.83 - 7.81) 2011 Modelled IHME
5.85 (3.76 - 7.88) 2010 Modelled IHME
6.55 (4.21 - 8.65) 2009 Modelled IHME
8.23 (5.28 - 10.70) 2008 Modelled IHME
10.25 (6.53 - 13.25) 2007 Modelled IHME
11.97 (7.59 - 15.39) 2006 Modelled IHME
12.76 (8.17 - 16.50) 2005 Modelled IHME
12.84 (8.43 - 16.22) 2004 Modelled IHME
12.89 (8.63 - 16.27) 2003 Modelled IHME
12.93 (8.73 - 16.20) 2002 Modelled IHME
12.97 (8.89 - 16.54) 2001 Modelled IHME
13.02 (8.95 - 16.60) 2000 Modelled IHME
13.22 (9.10 - 16.70) 1999 Modelled IHME
13.57 (9.09 - 17.22) 1998 Modelled IHME
13.97 (9.12 - 18.09) 1997 Modelled IHME
14.3 (9.21 - 18.79) 1996 Modelled IHME
14.44 (9.23 - 19.16) 1995 Modelled IHME
14.44 (9.23 - 19.13) 1994 Modelled IHME
14.42 (9.26 - 19.06) 1993 Modelled IHME
14.38 (9.27 - 18.94) 1992 Modelled IHME
14.29 (9.20 - 18.51) 1991 Modelled IHME
14.16 (9.03 - 18.11) 1990 Modelled IHME
7.47 (3.70 - 13.98) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
53 (45 - 62) 2019 Modelled IHME
53 (45 - 62) 2018 Modelled IHME
53 (45 - 62) 2017 Modelled IHME
54 (46 - 62) 2016 Modelled IHME
54 (46 - 63) 2015 Modelled IHME
54 (46 - 63) 2014 Modelled IHME
54 (46 - 62) 2013 Modelled IHME
54 (46 - 63) 2012 Modelled IHME
54 (45 - 62) 2011 Modelled IHME
54 (45 - 62) 2010 Modelled IHME
53 (45 - 62) 2009 Modelled IHME
53 (45 - 62) 2008 Modelled IHME
54 (45 - 62) 2007 Modelled IHME
53 (45 - 62) 2006 Modelled IHME
53 (45 - 62) 2005 Modelled IHME
53 (45 - 62) 2004 Modelled IHME
53 (45 - 62) 2003 Modelled IHME
53 (44 - 62) 2002 Modelled IHME
53 (44 - 62) 2001 Modelled IHME
53 (44 - 62) 2000 Modelled IHME
53 (44 - 62) 1999 Modelled IHME
53 (44 - 62) 1998 Modelled IHME
53 (44 - 62) 1997 Modelled IHME
53 (44 - 62) 1996 Modelled IHME
53 (44 - 62) 1995 Modelled IHME
53 (44 - 62) 1994 Modelled IHME
53 (44 - 62) 1993 Modelled IHME
53 (44 - 62) 1992 Modelled IHME
53 (44 - 62) 1991 Modelled IHME
53 (44 - 62) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
45 2018 Survey/reported WHO/UNICEF
45 2017 Survey/reported WHO/UNICEF
45 2016 Survey/reported WHO/UNICEF
45 2015 Survey/reported WHO/UNICEF
44 2014 Survey/reported WHO/UNICEF
50 2013 Survey/reported WHO/UNICEF
57 2012 Survey/reported WHO/UNICEF
63 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
57 2009 Survey/reported WHO/UNICEF
57 2008 Survey/reported WHO/UNICEF
57 2007 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.93 (2.34 - 3.69) 2019 Modelled IHME
2.94 (2.36 - 3.69) 2018 Modelled IHME
2.95 (2.36 - 3.69) 2017 Modelled IHME
2.97 (2.38 - 3.69) 2016 Modelled IHME
2.98 (2.40 - 3.70) 2015 Modelled IHME
3.01 (2.42 - 3.72) 2014 Modelled IHME
3.03 (2.45 - 3.75) 2013 Modelled IHME
3.06 (2.47 - 3.79) 2012 Modelled IHME
3.08 (2.49 - 3.83) 2011 Modelled IHME
3.11 (2.51 - 3.89) 2010 Modelled IHME
3.14 (2.53 - 3.92) 2009 Modelled IHME
3.16 (2.54 - 3.95) 2008 Modelled IHME
3.19 (2.56 - 3.99) 2007 Modelled IHME
3.22 (2.59 - 4.03) 2006 Modelled IHME
3.24 (2.59 - 4.07) 2005 Modelled IHME
3.27 (2.62 - 4.10) 2004 Modelled IHME
3.29 (2.65 - 4.13) 2003 Modelled IHME
3.32 (2.68 - 4.15) 2002 Modelled IHME
3.34 (2.71 - 4.17) 2001 Modelled IHME
3.36 (2.72 - 4.21) 2000 Modelled IHME
3.38 (2.73 - 4.23) 1999 Modelled IHME
3.39 (2.74 - 4.25) 1998 Modelled IHME
3.4 (2.74 - 4.27) 1997 Modelled IHME
3.42 (2.75 - 4.29) 1996 Modelled IHME
3.43 (2.75 - 4.30) 1995 Modelled IHME
3.45 (2.78 - 4.32) 1994 Modelled IHME
3.47 (2.81 - 4.34) 1993 Modelled IHME
3.49 (2.82 - 4.38) 1992 Modelled IHME
3.51 (2.82 - 4.40) 1991 Modelled IHME
3.53 (2.84 - 4.42) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
15 (11 - 21) 2019 Modelled IHME
15 (11 - 21) 2018 Modelled IHME
15 (11 - 21) 2017 Modelled IHME
15 (11 - 21) 2016 Modelled IHME
15 (11 - 21) 2015 Modelled IHME
15 (11 - 21) 2014 Modelled IHME
16 (11 - 21) 2013 Modelled IHME
16 (11 - 21) 2012 Modelled IHME
16 (11 - 22) 2011 Modelled IHME
16 (11 - 22) 2010 Modelled IHME
16 (11 - 22) 2009 Modelled IHME
16 (11 - 23) 2008 Modelled IHME
16 (11 - 22) 2007 Modelled IHME
17 (11 - 23) 2006 Modelled IHME
17 (11 - 23) 2005 Modelled IHME
17 (11 - 23) 2004 Modelled IHME
17 (11 - 23) 2003 Modelled IHME
17 (11 - 23) 2002 Modelled IHME
17 (11 - 23) 2001 Modelled IHME
17 (11 - 23) 2000 Modelled IHME
17 (11 - 23) 1999 Modelled IHME
17 (11 - 23) 1998 Modelled IHME
17 (11 - 23) 1997 Modelled IHME
17 (11 - 23) 1996 Modelled IHME
17 (11 - 23) 1995 Modelled IHME
17 (11 - 23) 1994 Modelled IHME
17 (11 - 23) 1993 Modelled IHME
17 (11 - 23) 1992 Modelled IHME
17 (11 - 23) 1991 Modelled IHME
17 (11 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
11.74 (%)
2019
(9.47 - 13.58(%))
IHME
HCV (RNA/cAg+)
2.93 (%)
2019
(2.34 - 3.69(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2,267
2019
(1,667 - 3,018)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
450
2019
(305 - 628)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
6.36 (%)
2019, latest modelled
(4.26 - 8.06(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines